AXSOME THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 683.20K shares, a 215.31% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 378.57K shares, a 14.08% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 560.29K shares, a 943.70% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 389.54K shares, a 17.36% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.50M shares, a 108.64% increase from fiscal 2024.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 718.16K shares, a 100.18% increase from fiscal 2023.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 358.76K shares, a 5.47% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 340.15K shares, a 4.27% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 683.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 2.01M shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 378.57K shares 10-Q · filed 2026-05-04 | 1.55M shares derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | 560.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 1.50M shares 10-K · filed 2026-02-23 |
| 2025-09-30 | 389.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 991.75K shares derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-06-30 | 216.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 1.07M shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 331.85K shares 10-Q · filed 2025-05-05 | 969.72K shares derived: sum of 4 quarters · filed 2025-05-05 |
| 2024-12-31 | 53.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 718.16K shares 10-K · filed 2025-02-18 |
| 2024-09-30 | 471.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 692.85K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 112.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 353.01K shares derived: sum of 4 quarters · filed 2024-08-05 |
| 2024-03-31 | 80.29K shares 10-Q · filed 2024-05-06 | 410.18K shares derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | 28.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | 358.76K shares 10-K · filed 2024-02-23 |
| 2023-09-30 | 131.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 399.16K shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 170.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 514.32K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 28.88K shares 10-Q · filed 2023-05-09 | 351.01K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 68.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 340.15K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 246.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 399.47K shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 6.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 188.42K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 18.02K shares 10-Q · filed 2022-05-02 | 250.23K shares derived: sum of 4 quarters · filed 2022-05-02 |
| 2021-12-31 | 128.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 326.22K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 35.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 202.44K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 68.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 209.67K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 94.00K shares 10-Q · filed 2021-05-10 | 161.59K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 4.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 127.78K shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 42.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 134.47K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 20.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 220.85K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 60.19K shares 10-Q · filed 2020-05-11 | 260.14K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 11.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 252.77K shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 129.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 520.68K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 59.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 391.46K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | 52.82K shares 10-Q · filed 2019-05-09 | 331.74K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | 278.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 278.93K shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 5.77K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 31.97K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | 46.38K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | 5.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 88.92K shares 10-K · filed 2018-03-07 |
| 2017-09-30 | 26.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 88.15K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 14.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 65.95K shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 42.54K shares 10-Q · filed 2017-05-09 | 51.54K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 9.00K shares 10-K · filed 2017-03-07 |
| 2016-09-30 | 4.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | |
| 2016-03-31 | 0.00 shares 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |